ClinicalTrials.gg
RecruitingNCT06668415Updated Oct 31, 2024

Effects of Spencer Technique Following Hydrodilation in Patients With Adhesive Capsulitis

An interventional study of Hydro dilation and Spencer muscle energy technique in Adhesive Capsulitis, sponsored by Foundation University Islamabad. Recruiting at 1 site in Pakistan. Open to participants aged 40 Years to 65 Years. Per ClinicalTrials.gov, last updated 2024-10-31.

Sponsored by Foundation University Islamabad · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 3 months after the study started (first participant enrolled Jul 2024, registered Oct 2024).
  • Started Jul 2024; still recruiting 2 years 3 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
40 Years to 65 Years
Sex
All
01

Study summary

Adhesive Capsulitis is a common Musculoskeletal disorder characterized by pain and progressive joint restriction in capsular pattern. Adhesive capsulitis can be managed by both conservative and non conservative treatment. The Spencer technique and hydrodilation are two treatment approaches used to restore range of motion in adhesive capsulitis.

The Spencer technique is a form of physical therapy that involves joint mobilizations and manual stretching exercises. It aims to improve shoulder mobility and reduce pain by addressing the tightness and stiffness in the shoulder capsule and surrounding tissues.

Hydrodilation, on the other hand, is a procedure where a saline solution is injected into the shoulder joint to distend the capsule. This distention helps stretch the tight tissues and break up adhesions, facilitating improved range of motion.

Read the detailed description

Adhesive capsulitis, also subsequently known as Frozen shoulder is a musculoskeletal disorder characterized by painful and progressive joint restriction in capsular pattern. It has a prevalence of 2 to 5% in general population and the incidence is more in females mostly aged 40 to 60 years mostly suffering from Diabetes Mellitus. Adhesive Capsulitis can be classified into three phases; Freezing (painful), Frozen (stiffening) and Thawing (resolution phase). The treatment protocol is planned such to improve the range of motion and reduce pain. Various treatment regimes are followed for treatment of adhesive capsulitis, either it be in medical field, physical therapy or in worst cases surgical treatments too.

Hydrodilation, a medical procedure which involves injecting a fluid (mainly normal saline) into the joint space which expands the space breaking up scar tissue and loosening the joint. This method is being widely used in isolation or in combination with other methods to treat Adhesive capsulitis.

Spencer technique on another hand is a physical therapy technique which in isolation or in conjunction with other treatments is used to treat patients with adhesive capsulitis. Spencer muscle energy technique is a seven 7 step procedure which consists of shoulder extension with elbow flexed, shoulder flexion with elbow flexed, circumduction with compression, circumduction with traction, Abduction then adduction with external rotation and glenohumeral pump.

Hence the current study will investigate the effects of Spencer technique following hydrodilation in patients with Adhesive Capsulitis.

The study includes subjects with unilateral adhesive capsulitis, 40-60 years of age both male and female and have undergone Hydrodilation. The selction of subjects will be using non probability purposive sampling technique. Participants will be randomized using sealed envelope method and allocated to one of two groups.

The data collection tool for pain is VAS, for ROM is Goniometer and for disability is SPADI.

The time duration for treatment protocol is total of 12 sessions, 3 sessions per week. Exercise is done 3 to 5 times with rest periods.

02

Conditions studied

  • Adhesive Capsulitis

Browse trials for

Keywords

  • Hydrodilation, spencer technique, pain, functional disability, range of motion
03

In context

Bursitis

417 studies on the registry are indexed under Bursitis; 112 are open to participants now.

This study's planned enrollment of 30 is below the median of 45 across 376 interventional studies indexed under Bursitis.

Browse Bursitis studies →

Lead sponsor

Foundation University Islamabad is the lead sponsor of 253 studies on the registry; 140 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
40 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

Inclusion Criteria:

  • Patients with diagnosed unilateral Adhesive Capsulitis and have undergone Hydrodilation. --Includes both genders
  • Age 40 to 60 years. Exclusion Criteria
  • Population who have recently undergone major shoulder injury or surgery, had fracture or open wound or there is reduction of Glen humeral ROM due to any other cause other than Adhesive Capsulitis
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
30 participants (estimated)

Study arms

  • Active comparator
    Group A (Hydrodilation+Spencer Technique )

    Patients in this group will be followed by Spencer Technique after Hydrodilation for the duration of 4 weeks which includes 12 sessions in total. Spencer muscle energy technique is a seven 7 step procedure which consists of shoulder extension with elbow flexed, shoulder flexion with elbow flexed, circumduction with compression, circumduction with traction, Abduction then adduction with external rotation and glenohumeral pump. Following the complete action, patients will be encouraged to use their muscles for 3 to 5 seconds against little resistance provided by the therapist

    Procedure: Hydro dilation · Procedure: Spencer muscle energy technique

  • Experimental
    Group B (Hydro dilation+ Passive Stretching)

    This group will undergo Passive Stretching followed by Hydrodilation. The low intensity stretches will be given in supine for all the movements ie Flexion ,Abduction , Internal Rotation and External Rotation for 5 repititions with 30 sec hold. (7)

    Procedure: Hydro dilation · Procedure: Passive Stretching

Interventions

  • ProcedureHydro dilation

    The hydro dilation injections comprises of Depomedrol 80mg and normal saline 0.9%. It is performed under fluoroscopic guidance by the orthopedic surgeon.

  • ProcedureSpencer muscle energy technique

    Spencer muscle energy technique is a seven 7 step procedure which consists of shoulder extension with elbow flexed, shoulder flexion with elbow flexed, circumduction with compression, circumduction with traction, Abduction then adduction with external rotation and glenohumeral pump. Following the complete action, patients will be encouraged to use their muscles for 3 to 5 seconds against little resistance provided by the therapist

  • ProcedurePassive Stretching

    The low intensity stretches will be given in supine for all the movements ie Flexion ,Abduction , Internal Rotation and External Rotation for 5 repititions with 30 sec hold.

06

What researchers measure

Primary outcomes

  1. Shoulder ROM

    Range of Motion will be measured using the universal Goniometer which is 0 to 180 degree for half circle model or 0 to 360 degree for full circle models.

    Time frame: 4 weeks

  2. Pain Intensity

    Pain will be assessed using Visual Analog scale which is 0-100 item scale.

    Time frame: 04 Weeks

Secondary outcomes

  1. Shoulder Disability

    Shoulder Disability will be assessed using shoulder pain and disability index.

    Time frame: 4 weeks

07

Study locations

1 of 1 sites recruiting
  • Foundation University College of Physical Therapy
    Rawalpindi, Punjab Province 46000, Pakistan
    Recruiting
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jul 2024 to primary completion in Oct 2024, 2 months.

Of 233 non-industry interventional studies with no phase under Bursitis, half reached primary completion within 10 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 16. This study's 2 months is below that.

Counting every sponsor, half of 233 studies reached it within 10 months; a quarter within 5 and three quarters within 16.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 30, 2024
First posted
Oct 31, 2024
StartActual
Jul 20, 2024
Primary completionActual
Oct 1, 2024
CompletionEst.
Oct 31, 2024
Last update
Oct 31, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Oct 31, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06668415
Responsible party
Sponsor
First posted
Oct 31, 2024
Start date
Jul 20, 2024
Primary completion
Oct 1, 2024
Completion
Oct 31, 2024 (estimated)
Last update
Oct 31, 2024

Study contacts

Javeria Ilyas, MS-MSKPT*
Contact
javeria.ilyas95@gmail.com
+923335888256

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion